Brown Brothers Harriman & Co’s Teladoc Health TDOC Stock Holding History

Brown Brothers Harriman & Co’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-506	Closed	-$3.54K	–	1907
2025 Q4	$3.54K	Buy	506 +275	+119%	+$2.15K	﹤0.01%	1600
2025 Q3	$1.79K	Hold	231	–	–	﹤0.01%	1588
2025 Q2	$2.01K	Buy	+231	New	+$1.67K	﹤0.01%	1412
2025 Q1	–	Sell	-10	Closed	-$91	–	1479
2024 Q4	$91	Buy	+10	New	+$97	﹤0.01%	1442
2022 Q3	–	Sell	-3	Closed	–	–	1585
2022 Q2	$0	Buy	+3	New	+$127	﹤0.01%	1409
2021 Q1	–	Sell	-500	Closed	-$100K	–	1236
2020 Q4	$100K	Sell	500 -350	-41%	-$71.2K	﹤0.01%	552
2020 Q3	$186K	Hold	850	–	–	﹤0.01%	399
2020 Q2	$162K	Hold	850	–	–	﹤0.01%	408
2020 Q1	$132K	Hold	850	–	–	﹤0.01%	413
2019 Q4	$71K	Buy	+850	New	+$64.7K	﹤0.01%	611
2018 Q1	–	Sell	-753,275	Closed	-$26.3M	–	1096
2017 Q4	$26.3M	Hold	753,275	–	–	0.14%	51
2017 Q3	$25M	Buy	+753,275	New	+$24.7M	0.13%	49

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Brothers Harriman & Co's TDOC Position: Q1 2026 in Review

Brown Brothers Harriman & Co sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 506 shares — an estimated $3.54K sold.

Brown Brothers Harriman & Co first reported a position in TDOC in Q3 2017 and held it in 12 quarters. The position peaked at $26.3M in Q4 2017. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Brown Brothers Harriman & Co reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
Brown Brothers Harriman & Co sold 506 Teladoc Health shares in Q1 2026, an estimated $3.54K.
Brown Brothers Harriman & Co first reported a position in Teladoc Health in Q3 2017 and held it in 12 quarters.
Brown Brothers Harriman & Co's Teladoc Health position peaked at $26.3M in Q4 2017.
325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.